Skyhawk Therapeutics, Inc. is a biotechnology company based in Waltham, MA, specializing in the development of innovative RNA-targeted therapies. The company focuses on harnessing its proprietary technology platform to design and optimize small molecules that can modulate RNA biology, aiming to address a range of serious diseases. With a commitment to advancing therapeutic solutions, Skyhawk is positioned at the intersection of molecular biology and drug development, contributing to the evolving landscape of precision medicine.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

13 Patents

#108 in Waltham, MA

#1,442 in Massachusetts

#23,838 in US

#45,039 in the World

Waltham, MA, United States of America

Skyhawk Therapeutics, Inc.

Forward Citations = 13

8 inventors:

Michael Luzzio (13 out of 54 patents)

Kathleen McCarthy (9 out of 9 patents)

William Haney (7 out of 22 patents)

4. Brian Stuart Lucas (4 out of 21 patents)

5. Tiansheng Wang (2 out of 68 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Skyhawk Therapeutics, Inc.. Retrieved from https://idiyas.com/company/skyhawk-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

5 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]